ReviewTherapeutic advances in respiratory disease

Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience.

Catharina Belge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.